However, when hyperglycemia is corrected by the glucose-lowering agents, such as insulin therapy, insulin secretion is restored, a phenomenon known as release of “glucose toxicity,” and correction of insulin resistance factors such as obesity also improves insulin secretion. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.